Page last updated: 2024-12-06
sulfodiphenylamine
Description
Sulfodiphenylamine is a colorless, crystalline compound that is used as an intermediate in the synthesis of dyes and pigments. It is also used as a vulcanization accelerator in the rubber industry. Sulfodiphenylamine is synthesized by the reaction of aniline with sulfuric acid. The reaction is carried out in the presence of a catalyst, such as mercury or iron. Sulfodiphenylamine is studied because of its potential uses in the synthesis of new and improved materials. Its importance lies in its role as a building block for a variety of organic compounds. Sulfodiphenylamine is also used in the manufacture of pharmaceuticals and agricultural chemicals. It is a versatile compound with a wide range of applications.'
sulfodiphenylamine: used to make single crystal silver nanowires; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
PubMed CID | 66866 |
SCHEMBL ID | 315795 |
MeSH ID | M0498505 |
Synonyms (34)
Synonym |
n-phenylsulfanilic acid |
diphenylamine-4-sulfonic acid |
p-anilinobenzenesulfonic acid |
4-diphenylaminesulfonic acid |
nsc-73722 |
sulfanilic acid, n-phenyl- |
n-phenylsufanilic acid |
benzenesulfonic acid, p-anilino- |
4-sulfodiphenylamine |
nsc73722 |
n-phenyl-p-aminobenzenesulfonic acid |
benzenesulfonic acid, 4-(phenylamino)- |
diphenylaminosulfonic acid |
101-57-5 |
4-anilinobenzenesulfonic acid |
nsc-163911 |
diphenylamine sulfonic acid |
p-anilinobenzenesulphonic acid |
unii-6e5xph8by9 |
einecs 202-955-0 |
sulfodiphenylamine |
6e5xph8by9 , |
nsc 73722 |
AKOS024332222 |
FT-0631538 |
n-phenylsulfanilic acid [mi] |
4-(phenylamino)benzenesulfonic acid |
SCHEMBL315795 |
DTXSID1059234 |
benzenesulfonic acid,4-(phenylamino)- |
diphenylaminsulfonsaure |
mfcd00065082 |
Q27264654 |
diphenylaminesulfonicacid |
Research
Studies (9)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 3 (33.33) | 24.3611 |
2020's | 1 (11.11) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 9 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |